Publications
Specialty
Search
Cath Lab Digest, CardioVascular, Journal of Invasive Cardiology, EP Lab Digest
09/06/2024
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
Oncology
09/06/2024
True or False: According to results from the AUGMENT trial, revumenib demonstrated high r
EMSWorld
09/06/2024
In our newest episode of EMS World Podcasts, host Mike McCabe chats with Dynarex executives John Burns, corporate training and events director, and Kristen Dreyer, product development manager, about their company's latest innovative products that enhance patient care as well as their commitment to supporting first responders and the EMS community.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/06/2024
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility, and excellent anti-calcification performance. In addition, this design allows for room temperature storage of the valve in a dry-tissue condition.
EP Lab Digest
09/06/2024
New Studies Highlight Enhanced Multimodal AI Analysis for Ventricular Tachycardia Mapping and Ablation
Oncology
09/06/2024
Pirtobrutinib treatment shows encouraging safety and activity among patients with relapsed/refractory B-cell malignancies who experience Richter transformation, according to a subgroup analysis from the phase 1/2 BRUIN study.
Psych Congress Network
09/06/2024
Lucia Cheng, MD, offers clinical pearls for mental health clinicians practicing in a telehealth setting.
Gastroenterology
09/06/2024
A new model better predicts postpolypectomy CRC diagnosis than the model based on polyp findings alone
Oncology
09/05/2024
According to updated results from the TROPiCS-03 trial, sacituzumab govetican showed promising antitumor activity among patients with both platinum-resistant and platinum-sensitive extensive-stage small cell lung cancer in the second-line setting.
Oncology
09/05/2024
According to results from the phase 2 DESTINY-CRC02 trial, 5.4 mg/kg of trastuzumab deruxtecan is preferable to 6.4 mg/kg among patients with HER2-positive metastatic colorectal cancer.
Journal of Clinical Pathways
09/05/2024
Luke Pike, MD, breaks down the TURBO-Non–Small Cell Lung Cancer study and summarizes the main findings.
Psychiatry & Behavioral Health, Psych Congress Network
09/05/2024
Cape Cod Symposium faculty members Raghu Appasani, MD, PC, Gaetano Vaccaro, PhD, CSAT, and Kaci Hohmann, JD, discuss the barriers and opportunities of psychedelic therapy in conventional psychiatric medicine and addiction recovery
EMSWorld
09/05/2024
As we approach the anniversary of the September 11th attacks, we honor the heroes who risked their lives that day and the countless others who have served in the aftermath. In our newest episode of EMS World Podcasts, host Mike McCabe sits down with former NYPD Commissioner William Bratton, former FDNY Fire Commissioner Salvatore Cassano, and former FDNY EMS Chief John Peruggia. Together, they reflect on the lessons learned from 9/11, the advancements made in emergency services since then, and the ongoing challenges faced by first responders.
Psychiatry & Behavioral Health, Psych Congress Network
09/05/2024
Cape Cod Symposium faculty members Raghu Appasani, MD, PC, Gaetano Vaccaro, PhD, CSAT, and Kaci Hohmann, JD, explore the therapeutic benefits of psychedelics, how psychedelics function as adjunctive therapies, and key legal considerations.
Lymphoma, Leukemia & Myeloma Network
09/05/2024
Combination venetoclax-ibrutinib treatment for patients with relapsed/refractory mantle cell lymphoma demonstrated durable responses and an acceptable toxicity profile, according to 7-year outcomes from the AIM clinical trial.
Oncology
09/05/2024
Pinkal Desai, MD discusses the challenges of existing treatment options for patients with secondary acute myeloid leukemia and the need for further development of therapies for this disease subset.
Psych Congress Network
09/05/2024
This video describes common challenges faced during the assessment of negative symptoms and cognitive impairment in people living with schizophrenia.
Psych Congress Network
09/05/2024
Patients with a particular cognitive biotype of treatment-resistant depression are more likely to experience improvement with TMS compared with other patients, study finds.
Oncology, Journal of Clinical Pathways
09/05/2024
Alessandro Santin, MD, shares insights from the endometrial cancer cohort of the TROPiCS-03 trial, which evaluated sacituzumab govetican among patients with advanced endometrial cancer who have been heavily pretreated.